|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_ForwardLookingEvaluationsAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
11.02.2021
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
2021 expectations are given below; Med Complex Margin Med Complex Refining Margin expectation is 0.0 – 0.5 $/bbl (no change) Tüpraş Net Margin Tüpraş Net Refining Margin expectation is 2.5 – 3.5 $/bb l (no change) Operational Targets Capacity utilization: 85-90% (previously: 90%-95%) Production: ~ 25-26 million tons (previously: 26-27) Total Sales: ~26-27 million tons (no change) Investments Total investments expectation is ~200 Million $ (no change) Due to the slower recovery in the demand for some products during the normalization period, revisions were made in our capacity utilization and production figures that we forecasted at the beginning of 2021. In case of a discrepancy between the Turkish and the English versions of this disclosure, the Turkish version shall prevail. |
||||||||